Welcome to our dedicated page for Ventas SEC filings (Ticker: VTR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ventas, Inc. filings document the regulatory record of a healthcare real estate investment trust whose common stock trades on the New York Stock Exchange under VTR. The company’s disclosures include Form 8-K reports for operating results, quarterly and annual earnings releases, dividend-related events, material financing agreements and capital markets activity.
Recent filings also cover amendments to credit facilities, registered senior notes issued by Ventas Realty, Limited Partnership and guaranteed by Ventas, ATM sales agreement updates, officer-transition disclosures and proxy materials addressing director elections, executive compensation, shareholder voting matters and governance.
Vanguard Capital Management reports beneficial ownership of 35,893,818 shares of Ventas Inc common stock, representing 7.55% of the class as reported for the period ending 03/31/2026. The filing shows sole voting power for 5,026,973 shares and sole dispositive power for 35,893,818 shares. The filing was signed on 04/30/2026 and includes a standard disclosure that ownership reflects assets managed by affiliated Vanguard business units.
Vanguard Portfolio Management LLC reported beneficial ownership of 41,321,002 shares of Ventas Inc common stock, representing 8.69% of the class as of 03/31/2026. The filing shows sole voting power for 59,037 shares and sole dispositive power for 41,321,002 shares. The Schedule 13G was signed on 04/29/2026.
Ventas, Inc. reports higher first-quarter 2026 results while actively recycling capital and strengthening its balance sheet. Total revenues rose to $1,656,944,000 from $1,358,074,000 a year earlier, driven mainly by strong growth in senior housing resident fees and services.
Net income attributable to common stockholders increased to $55,912,000, or basic earnings of $0.12 per share. Net operating income was led by the senior housing operating portfolio with $374,458,000, representing 57.5% of total NOI, followed by outpatient medical and research and triple-net leased properties.
The company continued to expand its SHOP segment, acquiring 29 senior housing communities for about $983.4 million in the quarter while selling 12 properties for $47.1 million and recognizing a $15.0 million gain. Operating cash flow was strong at $394,607,000, supporting significant investment and debt repayment activity.
Ventas, Inc. reported strong first quarter 2026 results driven by its senior housing operating portfolio. Attributable net income was $55.9 million, or $0.11 per diluted share, up from $46.9 million or $0.10 per share a year earlier.
Nareit FFO per share rose to $0.90 from $0.85, and Normalized FFO per share increased to $0.94 from $0.86, a 9% gain. Total revenues grew to $1.66 billion from $1.36 billion, supported by a more than 15% increase in Same-Store Cash NOI in the SHOP segment and 8.7% growth in total Same-Store Cash NOI.
The company closed $1.7 billion of senior housing investments year to date and raised its 2026 investment target to $3 billion. Ventas improved its Net Debt-to-Further Adjusted EBITDA to 5.0x and reported $5.5 billion of liquidity. Based on the strong start to the year, it increased full-year 2026 guidance for Attributable Net Income, Nareit FFO and Normalized FFO per share.
Ventas, Inc. director Maurice S. Smith reported acquiring small amounts of common stock units through compensation deferral programs. On April 16, 2026, he received 59.316 and 66.742 common stock units, both tied to dividend equivalents under non-employee director deferral arrangements and valued at the closing price of $85.51 per share on the grant date.
These units are payable solely in common stock under the terms of the company’s cash and equity award deferral programs. Following these awards, Smith directly holds a total of 28,675.671 shares of Ventas common stock.
Ventas, Inc. director Sumit Roy reported acquiring additional common stock units through dividend-equivalent awards, not open-market purchases. On April 16, 2026, he received 49.717 units and 66.742 units of common stock at a reference price of $85.51 per share under company director deferral programs. These awards, payable solely in common stock pursuant to his deferral elections, increased his directly held common stock to 22,357.224 shares.
Ventas, Inc. director Joe Vasquez Rodriguez Jr. received an equity award tied to his board compensation. He acquired 41.221 shares of common stock on April 16, 2026, valued at $85.51 per share, through units granted under the company’s Non-Employee Directors' Equity Award Deferral Program.
These units were credited as dividend equivalents on the company’s common stock and are payable solely in stock, under the terms of his deferral election and the program. Following this award, he directly holds 7,847.719 shares of Ventas common stock.
Ventas director Marguerite M. Nader received an equity award tied to dividend equivalents. On the dividend paid April 16, 2026, she acquired 66.742 common stock units under Ventas, Inc.’s Non-Employee Directors' Equity Award Deferral Program, valued at the closing price of $85.51 per share, bringing her directly held common stock to 21,424.958 shares.
Ventas, Inc. director Roxanne M. Martino acquired 188.32 shares of common stock through a grant under the company’s Non-Employee Directors' Cash Compensation Deferral Plan. The units were credited as dividend equivalents tied to the dividend paid on April 16, 2026 at a closing price of $85.51 per share.
Following this automatic, compensation-related acquisition, Martino directly holds a total of 64,081.021 shares of Ventas common stock.
Ventas, Inc. director Matthew J. Lustig acquired additional common stock units through company deferral programs tied to dividends. He received 229.231 units and 66.742 units of common stock, both valued at a closing price of $85.51 per share on the grant date. These awards were credited as dividend equivalents under the Non-Employee Directors' Cash Compensation Deferral Plan and the Non-Employee Directors' Equity Award Deferral Program and are payable solely in common stock. Following these grants, Lustig directly holds 92,958.712 shares of Ventas common stock.